Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Apr
14
2020
9:00—10:30 AM ET
April 06, 2020
As low- and middle-income countries prepare to be hard hit by the COVID-19 outbreak, policymakers must make tough choices on how to allocate finite resources to respond, especially considering constraints in human resources, infrastructure, and supply chains. Optimizing resource allocation—at all ti...
Blog Post
November 05, 2019
Though there are various definitions of HTA, and different approaches for considering evidence on clinical effectiveness, economics, social values, and ethics, there is a universal emphasis on generating transparent and evidence-informed recommendations for health coverage decisions.
...
Blog Post
May 23, 2019
Despite their intended use for rare diseases, so-called orphan drugs contribute substantially to prescription drug spending; in fact, it is estimated that in just two years’ time, orphan drugs will constitute more than 20 percent of the market for global pharmaceutical sales. Nowhere is t...